KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Sales (2016 - 2025)

Historic Return on Sales for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 0.01%.

  • AbbVie's Return on Sales fell 1000.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.08% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, AbbVie's Return on Sales is 0.01%, which was down 1000.0% from 0.06% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Return on Sales ranged from a high of 0.33% in Q1 2022 and a low of 0.0% during Q4 2024
  • Over the past 5 years, AbbVie's median Return on Sales value was 0.11% (recorded in 2024), while the average stood at 0.13%.
  • As far as peak fluctuations go, AbbVie's Return on Sales surged by 2700bps in 2021, and later crashed by -3100bps in 2023.
  • Quarter analysis of 5 years shows AbbVie's Return on Sales stood at 0.27% in 2021, then plummeted by -40bps to 0.16% in 2022, then plummeted by -65bps to 0.06% in 2023, then tumbled by -103bps to 0.0% in 2024, then soared by 882bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.06% for Q2 2025, and 0.1% during Q1 2025.